Eosinophilic Esophagitis (EE) Pediatric Research and Clinical Trials

LIke ThisLIke ThisLIke ThisLIke ThisLIke This

Contact the Eosinophilic Esophagitis Program

Boston Children’s Hospital is home to the world’s most extensive research enterprise at a pediatric hospital. We also have many partnerships with research, biotech and health care organizations, and we work together to find innovative ways to improve kids’ health.

The Eosinophilic Gastrointestinal Disease (EGID) Program joins several other centers of excellence within the Division of Gastroenterology, Hepatology and Nutrition, including those for IBD, liver disease, celiac disease, clinical nutrition, motility and functional gastrointestinal disorders and endoscopy. The Division of Allergy and Immunology cares for more than 6,000 children in New England, as well as children with rare immunodeficiencies from around the world.

While we are learning more about the cause and treatment of EGIDs, much remains uncertain. The EGID Program at Children’s is actively involved in cutting-edge research with basic science, clinical and translational studies, including investigating ways to recognize the presence of eosinophils without having to do an endoscopy.

You may be offered the opportunity to participate in a study. Please know that while conducting research is a very important mission of our program, your child’s care in the EGID Program will never be compromised should you decline to participate.

Boston Children’s is so much more than a hospital—it’s a community of researchers, clinicians, administrators, support staff, innovators, teachers, patients and families, all working together to make the impossible possible. ”
- Sandra L. Fenwick, President and CEO

Boston Children's Hospital
300 Longwood Avenue, Boston, MA 02115
For Patients: 617-355-6000
For Referring Providers: 844-BCH-PEDS | 844-224-7337